gruberamit retweeted
Wonderful to see our findings, published a year ago in @CircHF, reproduced so elegantly in @CircAHA. There's no better validation than independent replication!
The road to new HFpEF drugs starts with an organoid model.
ahajournals.org/doi/10.1161/…
gruberamit retweeted
Always flattering when a leading lab validates your work, almost step by step. Our HFpEF organoid findings, published in @CircHF a year ago, now beautifully reproduced in @CircAHA.
For anyone interested (reference lists included), here's where it started:
ahajournals.org/doi/10.1161/…
🫀 New in @CircAHA. We systematically developed a "HFpEF" cocktail to model impaired cardiac relaxation across human heart cells, organoids, and engineered tissues. Congratulations to all authors!
@StanfordCVI @StanfordMed @GreenstoneBio @Stanford_ChEMH
ahajournals.org/doi/10.1161/…
gruberamit retweeted
Efficacy of ambulatory intravenous diuresis for chronic heart failure patients: Insights from the DEA-HF trial see @ ow.ly/oI8M50YyWel
@EJHFEiC @JanBiegus @Ppponikowski #HFA_ESC @hvanspall @ShelleyZieroth @FudimMarat @gcfmd @MarcoMetra @GianluSava
gruberamit retweeted
Innovation takes many forms!
It is most rewarding when established care models are proven effective.
We’re proud that the pooled results of our DEA-HF study highlight this invaluable modality as a highly effective strategy for HF management - and help support its broader adoption
Efficacy of ambulatory intravenous diuresis for chronic heart failure patients: Insights from the DEA-HF trial see @ ow.ly/oI8M50YyWel
@EJHFEiC @JanBiegus @Ppponikowski #HFA_ESC @hvanspall @ShelleyZieroth @FudimMarat @gcfmd @MarcoMetra @GianluSava